Abstract

Making use of modeling and simulations: Towards individualized tamoxifen therapy inbreast cancer .

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan
M Kimura ... S Miura
Annals of Oncology | VOL. 11
M Kimura, et. al.M Kimura ... S Miura
01 Dec 2000
Tamoxifen therapy for breast cancer and endometrial cancer risk.
D Deapen ... J Liff
Journal of the National Cancer Institute | VOL. 91
D Deapen, et. al.D Deapen ... J Liff
06 Oct 1999
Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group.
L E Rutqvist
Journal of the National Cancer Institute | VOL. 85
L E RutqvistL E Rutqvist
01 Sep 1993
Profound reduction in tamoxifen active metabolite endoxifen in a breast cancer patient treated with rifampin prior to initiation of an anti-TNFα biologic for ulcerative colitis: a case report.
Sara L Henderson ... Richard B Kim
BMC cancer | VOL. 16
Sara L Henderson, et. al.Sara L Henderson ... Richard B Kim
11 May 2016
View more papers

More From: International journal of clinical pharmacology and therapeutics

Paper Title
Journal
Date
Author
Risk factors for infliximab-induced infusion reactions based on a retrospective study of medical information.
Takahiro Amemiya ... Hiroshi Suzuki
International journal of clinical pharmacology and therapeutics | VOL. -
Takahiro Amemiya, et. al.Takahiro Amemiya ... Hiroshi Suzuki
10 May 2024
Activated charcoal helps in the diagnosis of dabigatran overdose: Acase study.
Ning Zhang ... Songsong Lu
International journal of clinical pharmacology and therapeutics | VOL. -
Ning Zhang, et. al.Ning Zhang ... Songsong Lu
10 May 2024
Degree of serum LDL cholesterol reduction by simvastatin and ezetimibe is dependent on baseline LDL cholesterol concentration but not on baseline values and changes of cholesterol synthesis and absorption parameters.
Dieter Lütjohann ... Frans Stellaard
International journal of clinical pharmacology and therapeutics | VOL. -
Dieter Lütjohann, et. al.Dieter Lütjohann ... Frans Stellaard
03 May 2024
Palatability evaluation of orally disintegrating tablets using a visual analog scale in clinical trials.
Motoyasu Miura ... Shinya Uchida
International journal of clinical pharmacology and therapeutics | VOL. -
Motoyasu Miura, et. al.Motoyasu Miura ... Shinya Uchida
03 May 2024
View more papers